Preclinical Imaging MarketPosted by ahila on April 30th, 2018 Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others. Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market. A sample of this report is available upon request @ The preclinical imaging market has been segmented by type of product, application, and end-user Based on product type, preclinical imaging market segmented as:
Based on of application, preclinical imaging market is segmented as:
Based on the end-user, preclinical imaging market is segmented as:
To view TOC of this report is available upon request @ Like it? Share it! More by this author |